Sulfuric Acid

Sulfuric Acid

SCHEMBL4247474

CCCC[n+]1ccn(C)c1C.CCCC[n+]1ccn(C)c1C.O=S(=O)([O-])[O-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.44
CA2 P00918 5/20 0.44
EEF2K O00418 2/20 0.35
EEF2 P13639 2/20 0.35
BLM P54132 2/20 0.35
MEN1 O00255 1/20 0.35
PLK4 O00444 1/20 0.35
JAK2 O60674 1/20 0.35
EGFR P00533 1/20 0.35
TYK2 P29597 1/20 0.35
FLT3 P36888 1/20 0.35
KMT2A Q03164 1/20 0.35
ITK Q08881 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
RXFP1 Q9HBX9 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
HTT P42858 3/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL21195055 0.98 CA1 (0.43) CA1CA2EEF2KEEF2BLM
SCHEMBL4247119 0.95 CA1 (0.43) CA1CA2EEF2KEEF2BLM
Sulfuric Acid SCHEMBL21195056 0.94 CA1 (0.46) CA1CA2EEF2KEEF2BLM
SCHEMBL28771540 0.91 CA1 (0.40) CA1CA2EEF2KEEF2BLM
Trifluoromethanesulfonic Acid SCHEMBL707413 0.90 KCNH2 (0.41) CA1CA2EEF2KEEF2BLM
SCHEMBL294424 0.89 CA1 (0.51) CA1CA2EEF2KEEF2BLM
SCHEMBL28239043 0.89 CA1 (0.51) CA1CA2EEF2KEEF2BLM
SCHEMBL28943799 0.88 CA1 (0.39) CA1CA2EEF2KEEF2BLM
SCHEMBL28542529 0.88 CA1 (0.45) CA1CA2EEF2KEEF2BLM
Phosphoric Acid SCHEMBL29242957 0.88 CA1 (0.45) CA1CA2EEF2KEEF2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713501-B Preparation method of glucosamine calcium sulfate salt 山东润德生物科技有限公司 2021-04-06 CN claimed
CN-110684059-B Preparation method of D-glucosamine sulfate 山东润德生物科技有限公司 2020-08-28 CN claimed
CN-110684059-A Preparation method of D-glucosamine sulfate 山东润德生物科技有限公司 2020-01-14 CN claimed
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 EP claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
CN-111836849-B Process for producing fibers, films and moldings of polybenzazole polymer (P) 巴斯夫欧洲公司 2023-04-07 CN disclosed
CN-109790292-B Process for preparing polybenzazole polymer (P) 巴斯夫欧洲公司 2022-05-31 CN disclosed
EP-3762447-A1 METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2021-01-13 EP disclosed
US-20200407508-A1 METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2020-12-31 US disclosed
CN-111836849-A Process for producing fibers, films and moldings of polybenzazole polymer (P) 巴斯夫欧洲公司 2020-10-27 CN disclosed
WO-2019170529-A1 METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2019-09-12 WO disclosed
US-7897806-B2 Reacting primary amines with phosgene in ionic liquid as solvent BASF AKTIENGESELLSCHAFT (DE) 2011-03-01 US disclosed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES PGLS, INMT, PNMT CA1 2478/4885CA2 2076/4885EEF2K 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.